Wikidata

(Q53149038)

English

An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy.

scientific article published on 29 July 2011

In more languages
default for all languages
No label defined

No description defined

Statements

title
An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21803569
retrieved
11 May 2018
reference URL
http://europepmc.org/abstract/MED/21803569
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53149038&oldid=1878793447"